243 related articles for article (PubMed ID: 19927175)
1. Effect of cilostazol on cerebral arteries in secondary prevention of ischemic stroke.
Guo JJ; Xu E; Lin QY; Zeng GL; Xie HF
Neurosci Bull; 2009 Dec; 25(6):383-90. PubMed ID: 19927175
[TBL] [Abstract][Full Text] [Related]
2. Systematic study of cilostazol on secondary stroke prevention: a meta-analysis.
Qian Y; Bi Q
Eur J Med Res; 2013 Dec; 18(1):53. PubMed ID: 24313983
[TBL] [Abstract][Full Text] [Related]
3. Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study.
Huang Y; Cheng Y; Wu J; Li Y; Xu E; Hong Z; Li Z; Zhang W; Ding M; Gao X; Fan D; Zeng J; Wong K; Lu C; Xiao J; Yao C;
Lancet Neurol; 2008 Jun; 7(6):494-9. PubMed ID: 18456558
[TBL] [Abstract][Full Text] [Related]
4. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
[TBL] [Abstract][Full Text] [Related]
5. Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin.
Kamal AK; Naqvi I; Husain MR; Khealani BA
Cochrane Database Syst Rev; 2011 Jan; 2011(1):CD008076. PubMed ID: 21249700
[TBL] [Abstract][Full Text] [Related]
6. Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial.
Toyoda K; Uchiyama S; Yamaguchi T; Easton JD; Kimura K; Hoshino H; Sakai N; Okada Y; Tanaka K; Origasa H; Naritomi H; Houkin K; Yamaguchi K; Isobe M; Minematsu K;
Lancet Neurol; 2019 Jun; 18(6):539-548. PubMed ID: 31122494
[TBL] [Abstract][Full Text] [Related]
7. Benefit of cilostazol in patients with high risk of bleeding: subanalysis of cilostazol stroke prevention study 2.
Uchiyama S; Shinohara Y; Katayama Y; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C
Cerebrovasc Dis; 2014; 37(4):296-303. PubMed ID: 24820203
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the PreventIon of CArdiovascular events in iSchemic Stroke patients with high risk of cerebral hemOrrhage (PICASSO) study: A randomized controlled trial.
Hong KS; Kim BJ; Lee JY; Kwon SU;
Int J Stroke; 2015 Oct; 10(7):1153-8. PubMed ID: 26044566
[TBL] [Abstract][Full Text] [Related]
9. Pilot study of the safety of starting administration of low-dose aspirin and cilostazol in acute ischemic stroke.
Fujita K; Komatsu Y; Sato N; Higuchi O; Kujiraoka Y; Kamezaki T; Suzuki K; Matsumura A
Neurol Med Chir (Tokyo); 2011; 51(12):819-24. PubMed ID: 22198102
[TBL] [Abstract][Full Text] [Related]
10. Cilostazol Versus Aspirin for Secondary Stroke Prevention: Systematic Review and Meta-Analysis.
Lin MP; Meschia JF; Gopal N; Barrett KM; Ross OA; Ertekin-Taner N; Brott TG
J Stroke Cerebrovasc Dis; 2021 Mar; 30(3):105581. PubMed ID: 33388632
[TBL] [Abstract][Full Text] [Related]
11. Cilostazol Mono and Combination Treatments in Ischemic Stroke: An Updated Systematic Review and Meta-Analysis.
Kim SM; Jung JM; Kim BJ; Lee JS; Kwon SU
Stroke; 2019 Dec; 50(12):3503-3511. PubMed ID: 31607242
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
[TBL] [Abstract][Full Text] [Related]
13. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: protective effects of antiplatelet agents against stroke.
Shimazawa M; Hara H
J Pharmacol Sci; 2011; 116(1):30-5. PubMed ID: 21498958
[TBL] [Abstract][Full Text] [Related]
14. Dual Therapy with Aspirin and Cilostazol May Improve Platelet Aggregation in Noncardioembolic Stroke Patients: A Pilot Study.
Ohnuki Y; Ohnuki Y; Kohara S; Shimizu M; Takizawa S
Intern Med; 2017; 56(11):1307-1313. PubMed ID: 28566591
[TBL] [Abstract][Full Text] [Related]
15. Cilostazol versus aspirin therapy in patients with chronic dizziness after ischemic stroke.
Johkura K; Yoshida TN; Kudo Y; Nakae Y; Momoo T; Kuroiwa Y
Clin Neurol Neurosurg; 2012 Sep; 114(7):876-80. PubMed ID: 22336473
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease: Subanalysis of a Prospective Cohort.
Chiba T; Setta K; Shimada Y; Yoshida J; Fujimoto K; Tsutsui S; Yoshida K; Kobayashi M; Kubo Y; Fujiwara S; Terasaki K; Ogasawara K
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3373-3379. PubMed ID: 30174225
[TBL] [Abstract][Full Text] [Related]
17. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.
Lee YS; Bae HJ; Kang DW; Lee SH; Yu K; Park JM; Cho YJ; Hong KS; Kim DE; Kwon SU; Lee KB; Rha JH; Koo J; Han MG; Lee SJ; Lee JH; Jung SW; Lee BC; Kim JS
Cerebrovasc Dis; 2011; 32(1):65-71. PubMed ID: 21613787
[TBL] [Abstract][Full Text] [Related]
18. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats.
Oyama N; Yagita Y; Kawamura M; Sugiyama Y; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K
Stroke; 2011 Sep; 42(9):2571-7. PubMed ID: 21799161
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of cilostazol for the secondary prevention of ischemic stroke in acute and chronic phases in Asian population--an updated meta-analysis.
Shi L; Pu J; Xu L; Malaguit J; Zhang J; Chen S
BMC Neurol; 2014 Dec; 14():251. PubMed ID: 25527141
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy and safety of multiple antiplatelet therapies for secondary prevention of ischemic stroke or transient ischemic attack: A network meta-analysis.
Xiang RW; Han RB; Yang JY; Zhao MY; Zhao QC; Chen HS; Zhao FQ; Sun ZY; Zhao T; Song TY
J Neurol Sci; 2019 Apr; 399():199-206. PubMed ID: 30849580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
